Calcitriol
Predialysis Patients Calcitriol Oral Solution is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis.
United States
$11
per month
India
$0
per month
You save
−97%save $11/mo · 97% cheaper
1.3M US scripts/yr$14M potential annual savings$14.5M US spend/yr
Drag to rotate · 3D structureC27H44O3
SMILES: C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
Compare the price
US price$11per month
India price$1per month
You save$1092% less
Based on 30 units per month. US $0.36 vs India $0.03 per unit.
Total over 1 periodSave $10$11 → $1
The bigger picture
Calcitriol is filled about 1.3M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$14.5M
If sourced from India
$479.9K
Potential annual savings
$14M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.